Browse articles from EyeWorld.org related to keratoconus. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Alert: eye infections linked to artificial tear ➤ Phase 2 data from research targeting Sjogren’s treatment ➤ First patient dosed in Phase 1 study for epithelial defect treatment ➤ Study compares DMEK tissue preparation techniques ➤ Topline results from oral diabetic retinopathy treatment trial ➤ ASCRS news and events
➤ NDA submitted to FDA for drug that reverses mydriasis ➤ FDA cleared IND application for gene therapy to treat form of Leber congenital amaurosis ➤ FDA approves IND for research to move forward on RP gene therapy ➤ Phase 2 study to treat geographic atrophy begins ➤ Study: Weaning patients off of AMD treatments compared ➤ Possible geographic atrophy treatment explored ➤ ASCRS news and events
➤ FDA approves new therapy for amblyopia ➤ First-in-human data from IOL/drug-delivery platform ➤ Largest crosslinking study to date for keratoconus ➤ Interim data for Phase 2 trial evaluating choroidal melanoma treatment ➤ Gene therapy update ➤ SLT trial seeking more clinical sites, deadline October 14 ➤ Acquisition news ➤ ASCRS news and events
➤ Two-year results from Phase 3 study for GA therapy ➤ BLA resubmission for bevacizumab ➤ Strategic licensing for pharmacologic treatment for keratoconus ➤ Study: Gene therapy restores some cone function to otherwise colorblind children ➤ ASCRS news and events
➤ FDA approves image and data management/analysis platform ➤ Results from pivotal Phase 3 trial for new Demodex treatment ➤ Trial demonstrates safety, efficacy of mydriasis-reversal drug in pediatric patients ➤ Phase 3 pivotal trial for novel dry eye disease, MGD drug candidate ➤ Phase 3 results for investigational geographic atrophy therapy ➤ New coalition supports sustainability in ophthalmology ➤ ASCRS news and events
➤ Roberto Zaldivar, MD, delivers the Steinert Lecture ➤ Richard Lindstrom, MD, gives Obstbaum Lecture ➤ Video cases offer a ‘Reay of Hope’ at Glaucoma Day ➤ Cornea Day covers topics in keratoconus, corneal ectasia, lamellar surgery
➤ Results from pivotal amblyopia trial ➤ Phase 2 clinical program for third-generation keratoconus treatment ➤ Study compares tolerability of standard drop vs. novel drug delivery device ➤ Phase 3 clinical studies for investigational presbyopia drop complete ➤ Orphan drug designation granted for fungal keratitis treatment ➤ Full rights regained for investigational dry AMD therapy ➤ ASCRS news and events
“In this issue of EyeWorld, the official member publication of ASCRS, we highlight multiple areas of interest, including a number of sessions to be presented at the Annual Meeting that should not be missed,” said Eric Donnenfeld, MD, EyeWorld chief medical editor.
“If there was ever a top 10 list of issues on which eyecare as a whole could ‘up its game,’ it should include the fact that we all need to be more aggressive about educating patients on the fact that they can create their own self-induced keratoconus by repetitive pressure on their eyes,” according to EyeWorld Refractive Editor Vance Thompson, MD.
With keratoconus, it’s important to diagnose patients as early as possible in order to treat them before more drastic procedures, like a corneal transplant, might be needed. Crosslinking has aided in the early treatment of keratoconus, and now, the use of genetic testing is another tool for doctors to add to their armamentarium.
Get the latest ophthalmology news delivered to your inbox every Friday.